Aptose Biosciences (TSE:APS) Stock Price Passes Below 200-Day Moving Average – What’s Next?

Aptose Biosciences Inc. (TSE:APS) (NASDAQ:APTO) passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of C$9.25 and traded as low as C$2.75. Aptose Biosciences shares last traded at C$2.77, with a volume of 3,601 shares traded.

Wall Street Analyst Weigh In

Separately, Alliance Global Partners raised Aptose Biosciences to a “strong-buy” rating in a research note on Thursday, February 27th.

Aptose Biosciences Price Performance

The stock has a market cap of C$119.27 million, a PE ratio of -0.55 and a beta of 1.36. The company has a 50-day simple moving average of C$5.06 and a 200-day simple moving average of C$9.25. The company has a debt-to-equity ratio of -117.37, a current ratio of 1.05 and a quick ratio of 5.41.

Aptose Biosciences Company Profile

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.